ATPW
TXG icon

Ashton Thomas Private Wealth’s 10x Genomics TXG Stock Holding History

Ashton Thomas Private Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Buy
17,837
+2,685
+18% +$53.7K 0.01% 801
2025
Q4 		$247K Sell
15,152
-6,361
-30% -$96.1K 0.01% 891
2025
Q3 		$251K Buy
+21,513
New +$280K 0.01% 850
2024
Q3 		– Sell
-29
Closed -$564 – 1751
2024
Q2 		$564 Buy
+29
New +$759 ﹤0.01% 1892

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ashton Thomas Private Wealth's TXG Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its 10x Genomics (TXG) stake by 18% in Q1 2026, buying an estimated $53.7K and bringing the position to 17,837 shares worth $379K. The position accounts for 0.01% of the portfolio, ranked #801.

Ashton Thomas Private Wealth first reported a position in TXG in Q2 2024 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Ashton Thomas Private Wealth held 17,837 shares of 10x Genomics worth $379K as of Q1 2026.
  • Ashton Thomas Private Wealth bought 2,685 10x Genomics shares in Q1 2026, an estimated $53.7K.
  • 10x Genomics made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #801 holding.
  • Ashton Thomas Private Wealth first reported a position in 10x Genomics in Q2 2024 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.